DMI Life Sciences

DMI Life Sciences develops small molecule and peptide-based pharmaceuticals and biomarkers for acute and chronic inflammation.

DMI Life Sciences, Inc. is a biotechnology company. It discovers and develops small molecule and peptide-based pharmaceuticals and biomarkers for acute and chronic inflammation. The company is focused on immunologic, vascular and CNS diseases, including acute coronary syndrome, multiple sclerosis, Alzheimer’s disease, asthma, and cancer. DMI Life Sciences, Inc. was founded by David Bar and Michael Macaluso in 2009; and is headquartered in Greenwood Village, Colorado.